health.economictimes.indiatimes

Pathkind Labs, Roche Diagnostics partner to release cardiac biomarker

This announcement of NTProBNP comes in light of the growing burden of heart failure among T2D patients in India, inciting the need for urgent action. NTProBNP can directly predict adverse outcomes and ...
The Financial Express

Pathkind Labs and Roche Diagnostics partner to offer diabetes and cardiac care

In India, presently a total of 107 million adults have been diagnosed with Type 2 diabetes. (File) Pathkind Diagnostics on Friday announced that it has partnered with Roche Diagnostics to advance the ...
Indiatimes

MOPE invests Rs 194 cr in Pathkind Diagnostics for undisclosed stake

Mumbai, May 20 (PTI) Motilal Oswal Private Equity on Friday announced that a fund managed by it has made an investment of Rs 194.4 crore or USD 25 million in Pathkind Diagnostics for an undisclosed ...
Yahoo Finance

India Cancer Diagnostics Test Market Future Outlook to 2028, Featuring Aarthi Scans and Labs, Apollo Diagnostics, DNA Labs India, Fortis Healthcare, Pathkind Labs and Vijaya ...

Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "India Cancer Diagnostics Test Market: Test Price By Indication & Future Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The ...